🇺🇸 FDA
Pipeline program

hypo-fractionated SRS

H-26577

Phase 1 other completed

Quick answer

hypo-fractionated SRS for Metastatic Cancer is a Phase 1 program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Metastatic Cancer
Phase
Phase 1
Modality
other
Status
completed

Clinical trials